U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461116) titled 'Adverse Effects of ATG/ALG Therapy in Aplastic Anemia' on Feb. 24.
Brief Summary: This prospective, single-center, observational cohort study aims to systematically observe and describe the clinical characteristics of adverse reactions in patients with aplastic anemia undergoing ATG (Anti-Thymocyte Globulin) /ALG (Anti-Lymphocyte Globulin) treatment, providing a data foundation for the development of relevant management strategies. This study plans to enroll 200 aplastic anemia patients undergoing ATG/ALG treatment
Study Start Date: Feb. 23
Study Type: OBSERVATIONAL
Condition:
Aplastic Anaemia
Intervention:
DRUG: ATG/ALG
Par...